Weekend reads: China’s black market in publishing; no fraud in NgAgo gene editing work, says university; predatory journal crackdown

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a high-profile paper about cataract surgery and the risk of … Continue reading Weekend reads: China’s black market in publishing; no fraud in NgAgo gene editing work, says university; predatory journal crackdown

Weekend reads: How to get away with scientific fraud; what’s wrong with nutrition research; a second chance after misconduct

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a collaboration with Undark looking at how scientists who commit … Continue reading Weekend reads: How to get away with scientific fraud; what’s wrong with nutrition research; a second chance after misconduct

What took more than five years? Elsevier retracts 20 papers by world’s most prolific fraudster

In 2012, investigations found that researcher Yoshitaka Fujii had fabricated well in excess of 100 papers, and recommended scores of retractions. Yet years later, publishers are still cleaning the literature of his problematic work.   For anyone not familiar the Fujii case: After researchers raised concerns about Fujii’s work, an anesthesiologist used statistical tools to … Continue reading What took more than five years? Elsevier retracts 20 papers by world’s most prolific fraudster

Infamous case of fraud by protein crystallographer ends in 10-year funding ban

In 2009, a university announced a prominent researcher in the field of protein crystallography had likely fabricated nearly a dozen protein structures. Nine years later, the U.S. Office of Research Integrity (ORI) has upheld the results — and announced a relatively long sanction, by the agency’s standards. Today, the ORI placed a 10-year ban on … Continue reading Infamous case of fraud by protein crystallographer ends in 10-year funding ban

Weekend reads: No reproducibility crisis?; greatest corrections of all time; an archaeology fraud

The week at Retraction Watch featured the retraction of a paper on homeopathy whose authors had been arrested; news about 30 retractions for an engineer in South Korea; and a story about how two stem cell researchers who left Harvard under a cloud are being recommended for roles at Italy’s NIH. Here’s what was happening … Continue reading Weekend reads: No reproducibility crisis?; greatest corrections of all time; an archaeology fraud

Caught Our Notice: No retraction for “likely fraudulent” study

Title: Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson’s disease What Caught Our Attention:  In a letter to the editor, researchers led by Mark Bolland recently outlined the many reasons why a study by Yoshihiro Sato and colleagues in The American Journal of Medicine was “unreliable,” including evidence that the … Continue reading Caught Our Notice: No retraction for “likely fraudulent” study

Weekend reads: 20th anniversary of a fraud; uses and misuses of doubt; how common is scooping?

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation to support it?  The week at Retraction Watch featured the story of how two highly cited papers turned out to be wrong; a big prize for a researcher who has been dogged by … Continue reading Weekend reads: 20th anniversary of a fraud; uses and misuses of doubt; how common is scooping?

Weekend reads: Why following up on fraud matters; how many retractions in 2017?; misleading abstracts

The week at Retraction Watch featured the world energy solution that wasn’t, a story about Elsevier and fake peer reviews, and a question from a readers about citing retracted papers. Here’s what was happening elsewhere:

To catch a fraudster: Publisher’s image screening cuts down errata, “repeat offenders”

When a publisher rolls out image screening on its journals over an eight-year-period, some surprising things happen. For one, researchers whose papers were flagged are less likely to make the same mistake again. That’s according to new findings presented by the American Physiological Society (APS), which began increasingly checking images in accepted papers for splicing and other … Continue reading To catch a fraudster: Publisher’s image screening cuts down errata, “repeat offenders”

Weekend reads: Systemic fraud in China; science without journals; authorship rules decay

The week at Retraction Watch featured the retraction of a paper that had been called “anti-vaccine pseudoscience,” a retraction following threats of violence against an editor, and an editorial board member’s resignation over how a journal handled a case of plagiarism. Here’s what was happening elsewhere: